 Home > Active Ingredient News > Blood System > A landmark achievement in the research of artificial red blood cells in China-"Artificial Universal Blood" is about to enter the phase I clinical research phase

A landmark achievement in the research of artificial red blood cells in China-"Artificial Universal Blood" is about to enter the phase I clinical research phase

 Last Update: 2021-08-03
 Source: Internet
 Author: User

Tags

propranolol blood pressure

sudogest side effects

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On July 19, according to the Science and Technology Daily, the "artificial universal blood" developed by the National Micro-Detection Engineering Technology Research Center of Northwest University and the blood oxygen fluid R&D team of Xi'an Blood Oxygen Biotechnology Co.
, Ltd.
has completed the development of the "artificial universal blood" for rats, dogs and rats.
All animal experiments such as monkeys have passed the evaluation of the national authoritative new drug safety evaluation agency: side effects with no clinical significance, support the entry into phase I clinical research
.

The research and development of "artificial blood" innovative drugs has always been a hot spot and problem of international concern
.

So far, when human beings are facing major natural disasters, traffic accidents, clinical hemorrhages, wars and other emergency blood transfusion treatments, they often lose their lives because of insufficient blood or even "blood famine"

Blood vessel

The person in charge of the team said that the "artificial universal blood" has the characteristics of no matching, suitable for any blood type, on-demand, no risk of viral infection , large-scale preparation, and long shelf life.
When it is at a critical juncture due to blood loss, It can act as a bridge between "life" and "death"
.

In the next 3 to 4 years, this subversive technological achievement of hard science and technology that "changes" animal blood into human blood is expected to be applied to the clinic as a "breakthrough therapeutic drug", effectively solving the shortage of red blood cells of different blood types during clinical treatment, major disasters and wars.

Infected leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Food Additive Iron fumarate for Nutritional Iron Supplements

CAS No.: 141-01-5

Pharmacy Grade

$24-26/G FOB

Aminobenzoic Acid CAS 56-91-7

CAS No.: 56-91-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.